A multi-ancestry genetic study of pain intensity in 598,339 veterans

S Toikumo, R Vickers-Smith, Z Jinwala, H Xu, D Saini… - Nature Medicine, 2024 - nature.com
Chronic pain is a common problem, with more than one-fifth of adult Americans reporting
pain daily or on most days. It adversely affects the quality of life and imposes substantial …

[HTML][HTML] The promise of multi-omics approaches to discover biological alterations with clinical relevance in Alzheimer's disease

C Clark, M Rabl, L Dayon, J Popp - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
Beyond the core features of Alzheimer's disease (AD) pathology, ie amyloid pathology, tau-
related neurodegeneration and microglia response, multiple other molecular alterations and …

Characterization of apathy-like behaviors in the 5xFAD mouse model of Alzheimer's disease

R Keszycki, G Rodriguez, JT Dunn, A Locci… - Neurobiology of …, 2023 - Elsevier
Most patients with Alzheimer's disease (AD) develop neuropsychiatric symptoms (NPS)
alongside cognitive decline, and apathy is one of the most common symptoms. Few …

[HTML][HTML] Artificial Intelligence: Deciphering the Links between Psychiatric Disorders and Neurodegenerative Disease

GB Stefano, P Büttiker, S Weissenberger, T Esch… - Brain Sciences, 2023 - mdpi.com
Artificial Intelligence (AI), which is the general term used to describe technology that
simulates human cognition [1], has taken on a prominent role in twenty-first-century clinical …

[HTML][HTML] Distinctive whole-brain cell types predict tissue damage patterns in thirteen neurodegenerative conditions

V Pak, Q Adewale, D Bzdok, M Dadar, Y Zeighami… - Elife, 2024 - elifesciences.org
For over a century, brain research narrative has mainly centered on neuron cells.
Accordingly, most neurodegenerative studies focus on neuronal dysfunction and their …

Determining commonalities in the experiences of patients with rare diseases: A qualitative analysis of us food and drug administration patient engagement sessions

C Mease, LJ Fermaglich, K Jackler, S Shermer… - The Patient-Patient …, 2024 - Springer
Background Rare diseases are estimated to affect more than one in ten Americans.
However, most patients with a rare disease face significant emotional, physical, and social …

[HTML][HTML] The genetic architecture of pain intensity in a sample of 598,339 US veterans

S Toikumo, R Vickers-Smith, Z Jinwala, H Xu, D Saini… - medRxiv, 2023 - ncbi.nlm.nih.gov
Chronic pain is a common problem, with more than one-fifth of adult Americans reporting
pain daily or on most days. It adversely affects quality of life and imposes substantial …

[HTML][HTML] Neurodegeneration, mitochondria, and antibiotics

JM Suárez-Rivero, J López-Pérez, I Muela-Zarzuela… - Metabolites, 2023 - mdpi.com
Neurodegenerative diseases are characterized by the progressive loss of neurons,
synapses, dendrites, and myelin in the central and/or peripheral nervous system. Actual …

[HTML][HTML] Identifying potential risk genes and pathways for neuropsychiatric and substance use disorders using intermediate molecular mediator information

H Gedik, TH Nguyen, RE Peterson… - Frontiers in …, 2023 - frontiersin.org
Neuropsychiatric and substance use disorders (NPSUDs) have a complex etiology that
includes environmental and polygenic risk factors with significant cross-trait genetic …

Beyond memory impairment: the complex phenotypic landscape of Alzheimer's disease

S Argyriou, JF Fullard, JM Krivinko, D Lee… - Trends in Molecular …, 2024 - cell.com
Abstract Neuropsychiatric symptoms (NPSs) in Alzheimer's disease (AD) constitute
multifaceted behavioral manifestations that reflect processes of emotional regulation …